Nurix Therapeutics, Inc. Quarterly Return On Assets in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Nurix Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2021 to Q3 2024.
  • Nurix Therapeutics, Inc. Return On Assets for the quarter ending August 31, 2024 was -41.8 %, a 1.63% decline year-over-year.
  • Nurix Therapeutics, Inc. annual Return On Assets for 2023 was -41.6 %, a 1.54% increase from 2022.
  • Nurix Therapeutics, Inc. annual Return On Assets for 2022 was -42.2 %, a 69.8% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -41.8 -0.67 -1.63% Jun 1, 2024 Aug 31, 2024
Q2 2024 -44.4 -4.93 -12.5% Mar 1, 2024 May 31, 2024
Q1 2024 -43.6 -0.09 -0.21% Dec 1, 2023 Feb 29, 2024
Q4 2023 -41.6 +0.65 +1.54% Sep 1, 2023 Nov 30, 2023
Q3 2023 -41.1 -2.38 -6.14% Jun 1, 2023 Aug 31, 2023
Q2 2023 -39.4 -5.14 -15% Mar 1, 2023 May 31, 2023
Q1 2023 -43.5 -15.4 -54.7% Dec 1, 2022 Feb 28, 2023
Q4 2022 -42.2 -17.4 -69.8% Sep 1, 2022 Nov 30, 2022
Q3 2022 -38.8 -16.7 -75.9% Jun 1, 2022 Aug 31, 2022
Q2 2022 -34.3 -13.6 -65.8% Mar 1, 2022 May 31, 2022
Q1 2022 -28.1 Dec 1, 2021 Feb 28, 2022
Q4 2021 -24.9 Sep 1, 2021 Nov 30, 2021
Q3 2021 -22 Jun 1, 2021 Aug 31, 2021
Q2 2021 -20.7 Mar 1, 2021 May 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.